Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.22
05.12.23
-
05.12.24
-16.37%
09.12.23

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€10.38
28.11.23
€15.00
28.11.24
41.23%
09.12.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.52
30.11.23
-
30.11.24
22.33%
08.12.23

Could be very worthwhile Investment >20% year
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.44
02.12.23
€2.00
02.12.24
-1.29%
05.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€17.59
30.07.23
€30.00
31.12.25
51.89%
02.12.23

Could be very worthwhile Investment >20% year
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.23
23.11.23
€2.00
23.11.24
5.92%
29.11.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Digi Intl Inc.

Start price
Target price
Perf. (%)
€40.40
28.11.22
-
28.11.23
-46.04%
29.11.23

Significant cyclical dependencies
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€14.44
05.08.23
-
05.08.24
-28.81%
26.11.23

Fair valuation
High dividend yield expected
Small Risks for its business
Little Investments for future growth
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€5.90
12.11.23
-
12.11.24
18.64%
26.11.23

Risky Investment
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.15
12.11.23
-
12.11.24
12.15%
24.11.23

Could be very worthwhile Investment >20% year
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.11
27.09.23
€4.00
27.09.24
5.76%
23.11.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€16.20
17.11.22
€25.00
17.11.23
-77.54%
18.11.23

Small cyclical dependencies
Known brand
Capable Management
Top 10 in its market
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€1.07
12.11.23
€6.00
31.07.25
-
13.11.23

Could be very worthwhile Investment >20% year
buy
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.04
30.10.23
€7.80
30.10.24
-27.23%
13.11.23

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€7.52
23.12.22
€9.00
30.09.25
-79.54%
12.11.23

Could be very worthwhile Investment >20% year
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.21
30.10.23
-
30.10.24
-82.87%
11.11.23

Could be worthwhile Investment >10% per year
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.54
09.11.23
-
09.11.24
-19.21%
11.11.23

Could be worthwhile Investment >10% per year
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€39.80
30.10.23
€50.00
30.10.24
18.82%
11.11.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High valuation
Risky balance sheet
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€3.26
29.10.23
€4.00
29.10.24
-52.75%
11.11.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€3.26
30.10.23
-
30.10.24
-53.86%
10.11.23

Could be very worthwhile Investment >20% year
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.86
01.11.23
-
01.11.24
14.81%
10.11.23

Could be very worthwhile Investment >20% year
buy
Kopin Corp.

Start price
Target price
Perf. (%)
€1.31
04.09.23
€4.00
04.09.24
-3.97%
04.11.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€9.70
13.06.23
€17.00
31.10.23
-45.00%
31.10.23

Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.10
26.10.23
€8.00
26.10.24
-1.46%
30.10.23

Could be very worthwhile Investment >20% year